NCT07419997 A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Ischemic Stroke
| NCT ID | NCT07419997 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,600 participants |
| Start Date | 2025-12-29 |
| Primary Completion | 2026-12-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,600 participants in total. It began in 2025-12-29 with a primary completion date of 2026-12-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A multicenter, retrospective, observational cohort study on intravenous thrombolysis beyond the time window for acute ischemic stroke
Eligibility Criteria
1. Patients with acute ischemic stroke, regardless of gender; 2. Age ≥ 18 years old; 3. Time from onset to treatment within 4.5 - 24 hours (the onset time refers to the last time when they appeared normal); 4. Complete relevant clinical data (including gender, age, mRS, NIHSS, etc.).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07419997 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07419997 currently recruiting?
Yes, NCT07419997 is actively recruiting participants. Contact the research team at drxingxin@126.com for enrollment information.
Where is the NCT07419997 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07419997 clinical trial?
NCT07419997 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 2,600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.